Literature DB >> 19800930

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Elena I Deryugina1, James P Quigley.   

Abstract

A number of extensive reviews are available discussing the roles of MMPs in various aspects of cancer progression from benign tumor formation to overt cancer present with deadly metastases. This review will focus specifically on the evidence functionally linking the MMPs and tumor-induced angiogenesis in various in vivo models. Emphasis has been placed on the cellular origin of the MMPs in tumor tissue, the requirement of proMMP activation and the resulting proteolytic activity for the induction and progression of tumor angiogenesis, and the pleiotropic roles for some of the MMPs. The functional mechanisms of the angiogenic MMPs are discussed as well as their catalytic detection in complex biological systems. In addition, the contribution of active MMPs to metastatic spread and establishment of secondary metastasis will be discussed in view of the findings indicating that MMPs are involved in the preparation of pre-metastatic niches. Finally, the most recent evidence, indicating the pro-metastatic consequences of anti-angiogenic therapies employing MMP inhibitors will be presented as examples highlighting possible outcomes of interfering with the pleiotropic nature of the MMP functionality. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800930      PMCID: PMC2824055          DOI: 10.1016/j.bbamcr.2009.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  238 in total

Review 1.  Regulation of matrix biology by matrix metalloproteinases.

Authors:  Joni D Mott; Zena Werb
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

2.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

Authors:  Hiroaki Nozawa; Christopher Chiu; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

3.  Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.

Authors:  Heath B Acuff; Mark Sinnamon; Barbara Fingleton; Braden Boone; Shawn E Levy; Xiwu Chen; Ambra Pozzi; David P Carbone; Donald R Schwartz; Kamiar Moin; Bonnie F Sloane; Lynn M Matrisian
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

Review 5.  Stromal fibroblasts in cancer: a novel tumor-promoting cell type.

Authors:  Akira Orimo; Robert A Weinberg
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

6.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

Authors:  Li Yang; Laura M DeBusk; Koari Fukuda; Barbara Fingleton; Brenda Green-Jarvis; Yu Shyr; Lynn M Matrisian; David P Carbone; P Charles Lin
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

7.  A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.

Authors:  Lisa J McCawley; Howard C Crawford; Lloyd E King; John Mudgett; Lynn M Matrisian
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  Type IV collagenase/gelatinase (MMP-2) is not increased in plasma of patients with cancer.

Authors:  S Zucker; R M Lysik; M H Zarrabi; W Stetler-Stevenson; L A Liotta; H Birkedal-Hansen; W Mann; M Furie
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Sep-Oct       Impact factor: 4.254

9.  Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.

Authors:  W Brian Saunders; Brenda L Bohnsack; Jennifer B Faske; Nicholas J Anthis; Kayla J Bayless; Karen K Hirschi; George E Davis
Journal:  J Cell Biol       Date:  2006-10-09       Impact factor: 10.539

10.  Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis.

Authors:  P C Brooks; J M Lin; D L French; J P Quigley
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  76 in total

1.  Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Authors:  Jennifer Vandooren; Benjamin Born; Inna Solomonov; Ewa Zajac; Radka Saldova; Michael Senske; Estefanía Ugarte-Berzal; Erik Martens; Philippe E Van den Steen; Jo Van Damme; Angeles Garcia-Pardo; Matheus Froeyen; Elena I Deryugina; James P Quigley; Søren K Moestrup; Pauline M Rudd; Irit Sagi; Ghislain Opdenakker
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

2.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

3.  Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Authors:  Kevin A Goncalves; Guo-Fu Hu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-23

Review 4.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 5.  New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis.

Authors:  Beate Heissig; Makiko Ohki-Koizumi; Yoshihiko Tashiro; Ismael Gritli; Kaori Sato-Kusubata; Koichi Hattori
Journal:  Int J Hematol       Date:  2012-02-07       Impact factor: 2.490

6.  Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.

Authors:  Ewa Zajac; Bernhard Schweighofer; Tatyana A Kupriyanova; Anna Juncker-Jensen; Petra Minder; James P Quigley; Elena I Deryugina
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

Review 7.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 8.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

9.  Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

10.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.